Invesco Ltd. IVZ · NYSE
$28.21 -2.07% (-$0.60)
Summary
34 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $1.86B in the last fiscal year, 15% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Revenue grew by only 1.8% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 0.7% a year over 5 years. Over the last 3 years it grew by 1.8% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $64.5M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 2.95%
- Raised in a row
- 4 years
You receive $0.85 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 12
- Hold 16
- Sell 0
Today's price within the analysts' price targets
The average target of $33.71 is 20% above today's price. 43% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Investment Advice 72%
- Distribution and Shareholder Service 24%
- Financial Service, Other 3.2%
- Investment Performance 0.7%
By region
- Americas 75%
- EMEA, Excluding United Kingdom 21%
- Asia 4.6%
Investment Advice brings in 72% of revenue.
Segments in detail